Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-25-133312
Filing Date
2025-06-02
Accepted
2025-06-02 16:13:02
Documents
12
Period of Report
2025-03-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K/A d925343d8ka.htm   iXBRL 8-K/A 26806
  Complete submission text file 0001193125-25-133312.txt   148997

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rptx-20250331.xsd EX-101.SCH 2511
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rptx-20250331_lab.xml EX-101.LAB 19372
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rptx-20250331_pre.xml EX-101.PRE 12106
14 EXTRACTED XBRL INSTANCE DOCUMENT d925343d8ka_htm.xml XML 4746
Mailing Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9
Business Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39335 | Film No.: 251015086
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)